MainBoardListed
Corona Remedies Limited
Company websiteCorona Remedies Limited targets ₹61,71,102 crore, split as fresh issue ₹0 crore and OFS ₹61,71,102 crore.
The offer represents 14 shares. Apply from 08-12-2025 to 10-12-2025. Allotment on 11-12-2025, listing expected on 15-12-2025. Remember: subscription demand will influence listing-day price movements.
Start Date08-12-2025
End Date10-12-2025
Listing Date15-12-2025
Allotment Date11-12-2025
Current Price₹1,470
GMP₹344 (32.39%)
Lot Size14 Shares
Subscription144.49 Times
Face Value₹10 per share
Listing atNSE, BSE
Issue Price₹1008 - ₹1062
Pre Issue₹6,11,60,088
Post Issue₹6,11,60,088
Issue Size₹61,71,102
(aggregating up to 655.37 Cr)
(aggregating up to 655.37 Cr)
Fresh Issue
(aggregating up to 0.00 Cr)
(aggregating up to 0.00 Cr)
Offer For Sale₹61,71,102
(aggregating up to 655.37 Cr)
(aggregating up to 655.37 Cr)
The Grey Market Premium (GMP) for Corona Remedies Limited is currently around ₹344 (32.39%). This indicates an estimated listing price of approximately ₹1,352 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
14 Dec 2025, 15:45 | ₹1,062 | ₹344 | ₹1,406 (32.39%) |
14 Dec 2025, 07:18 | ₹1,062 | ₹315 | ₹1,377 (29.66%) |
14 Dec 2025, 15:31 | ₹1,062 | ₹342 | ₹1,404 (32.20%) |
14 Dec 2025, 12:46 | ₹1,062 | ₹328 | ₹1,390 (30.89%) |
13 Dec 2025, 05:18 | ₹1,062 | ₹320 | ₹1,382 (30.13%) |
12 Dec 2025, 11:24 | ₹1,062 | ₹335 | ₹1,397 (31.54%) |
11 Dec 2025, 08:53 | ₹1,062 | ₹291 | ₹1,353 (27.40%) |
10 Dec 2025, 11:15 | ₹1,062 | ₹270 | ₹1,332 (25.42%) |
09 Dec 2025, 17:09 | ₹1,062 | ₹225 | ₹1,287 (21.19%) |
08 Dec 2025, 10:46 | ₹1,062 | ₹222 | ₹1,284 (20.90%) |
07 Dec 2025, 05:34 | ₹1,062 | ₹259 | ₹1,321 (24.39%) |
06 Dec 2025, 11:40 | ₹1,062 | ₹310 | ₹1,372 (29.19%) |
05 Dec 2025, 09:15 | ₹1,062 | ₹310 | ₹1,372 (29.19%) |
04 Dec 2025, 12:11 | ₹1,062 | ₹310 | ₹1,372 (29.19%) |
03 Dec 2025, 10:37 | ₹1,062 | ₹265 | ₹1,327 (24.95%) |
02 Dec 2025, 12:24 | ₹1,062 | ₹0 | ₹1,062 (0.00%) |
Financials overview In Crores
Here is a quick look at the recent financial performance of Corona Remedies Limited . The numbers below ( In Crores ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
Key Performance
| KPI | Jun-25 | Mar-25 | Mar-24 |
|---|---|---|---|
EPS | 7.55 | 24.43 | 14.8 |
ROE | 7.61 | 27.50 | 20.36 |
ROCE | 11.28 | 41.32 | 31.19 |
RONW | 20.50 | 24.65 | 18.84 |
PRE IPO(PE) | 0 | 43.47 | 0 |
POST IPO(PE) | 35.15 | 0 | 0 |
Subscription Details (No. of Shares)
The below shows how many shares were subscribed by each investor category in the Corona Remedies Limited IPO. These numbers help you understand where the demand is coming from – whether it’s retail investors, QIBs, or NIBs. Higher subscription usually indicates strong interest and confidence from the market.
Subscription Demand (in ₹ Crore)
| Category | Offered | Demand | Times |
|---|---|---|---|
QIBs | ₹129.75 | 38119.37 | 293.79 |
FIs | ₹0 | 0.81 | 0.00 |
Others | ₹0 | 11.64 | 0.00 |
RETAIL | ₹227.22 | 6881.98 | 30.29 |
HNIs 2+ | ₹32.46 | 5427.21 | 167.20 |
HNIs 10+ | ₹64.92 | 16014.25 | 246.68 |
EMPLOYEES | ₹6.16 | 95.89 | 15.57 |
Total | ₹460.51 | 66538.70 | 144.49 |
Application Wise Breakup (Approx. no of Apps)
| Category | Reserved | Applied | Times |
|---|---|---|---|
RETAIL | 1,52,827 | 37,92,248 | 24.81 |
EMPLOYEES | 0 | 35,988 | 0.00 |
HNIs(10L +) | 3,119 | 1,55,224 | 49.77 |
HNIs (2-10L) | 1,559 | 2,49,992 | 160.35 |
Total | 1,57,505 | 41,97,464 | 26.65 |
The IPO reservation for Corona Remedies Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
Anchor | 29.73% | 18,34,804 |
QIB | 19.80% | 12,21,729 |
HNI | 14.86% | 9,16,960 |
RETAIL | 34.67% | 21,39,573 |
Market Maker | 0.94% | 58,036 |
TOTAL | 100.00% | 61,71,102 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail | 1 | 14 | ₹14,868 | |
sHNI | 14 | 196 | ₹2,08,152 | |
bHNI | 68 | 952 | ₹10,11,024 |
Below you can find the official contact details of Corona Remedies Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Phone: +91 79 4023 3000
Website: https://www.coronaremedies.com/
Address: CORONA House, C – Mondeal Business Park Near Gurudwara S. G. Highway Thaltej Ahmedabad, Gujarat, 380059